According to the latest report by IMARC Group, titled " Heart Failure Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033," the global heart failure market size is witnessing steady growth. Heart failure is a condition that occurs when the heart is unable to pump enough blood to meet the body's needs. The various causes of heart failure are coronary artery disease, high blood pressure, faulty heart valves, damage to the heart muscles, myocarditis, congenital heart defect, arrhythmias, diabetes, thyroid, and several viral infections. Additionally, it is also caused by heart failure due to fatigue, shortness of breath, swollen legs, and rapid or irregular heartbeat. Its treatment includes a combination of lifestyle changes, such as adopting a heart-healthy diet and engaging in regular exercise, as well as medication to improve the heart's ability to pump blood.
Global Heart Failure Market Trends:
The rising prevalence of chronic cardiovascular diseases among the masses is driving the global market. Moreover, the growing incidence of heart failure and rising incidence of diabetes, atherosclerosis, stroke, and hypertension are further catalyzing the market across the globe. In line with this, the unhealthy lifestyle habits of the masses, such as excessive smoking and drinking, are also contributing to the increasing incidence of heart problems among individuals. Due to the increasing awareness among individuals regarding the need to manage their heart health and early diagnosis and treatment of heart failure is fuelling the market across the globe. Furthermore, several leading players are heavily investing in the research and development of new drugs to reduce the risk of cardiovascular mortality and heart failure in adult patients, thus creating a positive market outlook. Along with this, the development of new technologies and devices, such as implantable cardiac devices, continuous glucose monitoring systems, and telemonitoring systems, are improving the management of heart failure, this is supporting the market. The market is further driven by the increasing healthcare expenditure and healthcare infrastructure in developed countries that helps in better diagnosis and treatment of heart failure. Besides, the utilization of a left ventricular assist device (LVAD) as a bridge for transplantation or destination therapy for patients who are not eligible for transplantation is also influencing the market.
- On the basis of the region, the market has been divided into the United States, German, France, the United Kingdom, Italy, Spain, and Japan.
- This research study also offers a thorough overview of late-stage pipeline candidates and currently marketed medications for heart failure.
- The study also offers a thorough overview of the treatment practices for heart failure, the share of specific therapies, and the performance of key market players.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800